Business is business. According to the UK business newspaper the Financial Times , companies Pharmaceuticals Pfizer and Moderna have increased the price of their coronavirus vaccine in as part of an agreement with the European Union.

The Pfizer vaccine goes from 14, 5 euros to 19, 5 euros and that of Moderna de 19 euros at 20, 5 euros depending on the newspaper that consulted the contract. This rise comes as concern over the delta variant outbreak is mounting and studies have proven that the vaccines from Moderna and Pfizer / BioNTech should remain effective against this variant.

Confidential contracts Asked by AFP, the European Commission refused to comment on the confidentiality of contracts. Contacted in turn by AFP, Pfizer and Moderna did not immediately react on Sunday.

The committee has always refused to communicate the price of the vaccines ordered. In December, a Belgian minister had published on Twitter – before deleting it – a table giving details of the amounts promised by its government to the manufacturers for each of the six vaccines ordered, with the unit price charged in the EU: from 1, 70 euro for the vaccine of the Swedish-British group AstraZeneca, at 16 US dollars (i.e. 04, 065 euros) for that of the American Moderna.

1.8 billion doses of Pfizer purchased In May, the EU signed a new contract to purchase up to 1.8 billion doses of vaccine from BioNTech-Pfizer deliverable until 2023, without revealing the price. In early July, European Commission President Ursula von der Leyen announced that the EU had reached its target of having enough doses in July to vaccinate 70% of its adult population (336 millions of people).

The program EU vaccine procurement has provided 330 millions of doses of BioNTech-Pfizer vaccine , 100 millions of the AstraZeneca, 50 millions of Moderna and 19 millions from Johnson & Johnson. At the end of July, the Pfizer laboratory planned to pass this year for 28, $ 5 billion (26, 23 billions of euros) of vaccines against Covid – 19, either more than the 23 billions of dollars (21, 91 billion euros) on which the group had counted two months earlier. Moderna, in May, expected annual sales of 18, $ 5 billion (15, 43 billions euros).